Assessing Tumor Response to Therapy
Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma
PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
The Role of Positron Emission Tomography and Computed Tomography Fusion in the Management of Early-Stage and Advanced-Stage Primary Head and Neck Squamous Cell Carcinoma
Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review
Integrating PET and PET/CT into the Risk-Adapted Therapy of Lymphoma
PET-CT for Therapy Response Assessment in Lymphoma
High-risk Melanoma- Accuracy of FDG PET-CT
Review of Evidence-Based Support for Pretreatment Imaging in Melanoma
Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer
PET Evaluation of Lung Cancer
Partnerships in Oncology and Radiology- The Role of Radiology in the Detection, Staging, and Follow-up of Lung Cancer
FDG PET-CT and Breast Cancer Imaging
Response to Therapy in Breast Cancer
18F-FDG PET and 18F-FDG PET-CT for Assessing Response to Therapy in Esophageal Cancer
Multimodality Assessment of Esophageal Cancer- Preoperative Staging and Monitoring of Response to Therapy
Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer - A Systematic Review
Colorectal Liver Metastases- CT, MR Imaging and PET for Diagnosis--Meta-analysis
The expanding role of PET technology in the management of patients with colorectal cancer
The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
Copyright 2008 Southwest PET/CT Institute